Home Tags Illumina

Tag: Illumina

Illumina

EU Antitrust Regulators Re-Start Illumina, Grail Probe

EU antitrust regulators have resumed their scrutiny of US life sciences company Illumina’s bid for Grail after a two-month temporary halt and will decide...
Illumina

Illumina Faces EU Interim Measures Over Grail Deal

US life sciences company Illumina faces interim measures for closing its US$8 billion cash-and-stock takeover of cancer detection test maker Grail before gaining approval...
Illumina

Republicans Question FTC’s Efforts To Halt Illumina’s Grail Deal

Two Republican lawmakers on Thursday questioned the Federal Trade Commission's (FTC) efforts to unwind life science company Illumina's US$7.1 billion acquisition of Grail, alleging the...
Illumina

EU Opens New Probe Into Illumina’s Closure Of Grail Deal

The European Union’s executive arm said it was opening a probe into Illumina’s decision to complete its US$7.1 billion purchase of Grail despite a continuing antitrust...
Illumina

Illumina Closes $8B Grail Merger Despite EU Probe

Illumina has closed its US$8 billion takeover of liquid biopsy player Grail despite an ongoing regulatory review by the European Union and pending US...
FTC

FTC Does Not See A Need For More Experts At Illumina...

The Federal Trade Commission (FTC) is resisting a bid from Illumina to call two additional witnesses at the agency's upcoming antitrust trial, claiming the request from...
Merger

Illumina Hires Sidley, DLA Piper To Lobby Against FTC Merger Challenge

Illumina ramped up its US lobbying spend in Washington, DC, in recent months, hiring law firms Sidley Austin and DLA Piper to advocate for...
Illumina

EU Is Concerned Illumina Deal For Grail Could Hurt Innovation

US life sciences company Illumina's proposed acquisition of cancer test maker Grail could curb innovation and competition, EU antitrust regulators warned Thursday as they...
Illumina

Illumina Sues EC To Block Antitrust Probe Into Grail Deal

Illumina has filed for an annulment of the European Commission's decision to assess the proposed takeover of Grail. The maker of gene sequencing machines...
deal

EU Probes Illumina’s $7.1B Grail Acquisition

EU antitrust regulators will examine Illumina’s proposed US$7.1 billion acquisition of cancer test maker, the European Commission announced on Tuesday, April 20, following a...
Enable Notifications    OK No thanks